Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker-Reference-Cited by-同舟云学术

Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker

Published:2020 Issue:2 Volume:9 Page:182-192
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Kim Chang Min,Hwang Shin,Keam Bhumsuk,Yu Yun Suk,Kim Ji Hoon,Kim Dong-Sik,Bae Si Hyun,Kim Gun-Do,Lee Jong Kyu,Seo Yong Bae,Nam Soon Woo,Kang Koo Jeong,Buonaguro Luigi,Park Jin Young,Kim Yun Soo,Wang Hee Jung

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference17 articles.

1. Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: current and future. World J Gastroenterol. 2013 Oct;19(37):6144–55.

2. Ocana A, Pandiella A, Siu LL, Tannock IF. Preclinical development of molecular-targeted agents for cancer. Nat Rev Clin Oncol. 2010 Dec;8(4):200–9.

3. Sokolenko AP, Imyanitov EN. Molecular diagnostics in clinical oncology. Front Mol Biosci. 2018 Aug;5:76.

4. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004 May;350(21):2129–39.

5. Tsao H, Chin L, Garraway LA, Fisher DE. Melanoma: from mutations to medicine. Genes Dev. 2012 Jun;26(11):1131–55.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma;Frontiers in Oncology;2024-06-27

2. Molecular profiling in the management of hepatocellular carcinoma;Current Opinion in Organ Transplantation;2023-12-01

3. Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma;Cancers;2023-08-23

4. Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma;Frontiers in Immunology;2023-05-19

5. HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features;Liver Cancer;2023-04-17